Federal Trade Commission Statement Concerning Brand Drug ...

Branded Manufacturers Decline to Remove Patents From the ...

In the wake of the FTC's letters, and the decision of branded pharmaceutical manufactures regarding delisting or keeping patents in the Orange ...

Over-the-Counter Drugs and Devices | Federal Trade Commission

Federal Trade Commission Statement Concerning Brand Drug Manufacturers' Improper Listing of Patents in the Orange Book ; Date. September 14, 2023 ; By. Federal ...

FTC warns drugmakers over improper patent filings - STAT News

Drugmakers could face legal action if they improperly list patents for brand-name medicines in a Food and Drug Administration registry.

File A Complaint | Federal Trade Commission

Find legal resources and guidance to understand your business responsibilities and comply with the law. ... Policy. We work to advance government policies that ...

Direct-to-Consumer Prescription Drug Advertisements

The Food and Drug Administration (FDA, the Agency, or we) is issuing a final rule to amend its regulations concerning direct-to- consumer ...

FTC Weighs In on Orange Book Listing of Drug-Device Patents

The Situation: On March 22, 2024, the Federal Trade Commission ("FTC") filed an amicus brief in Teva Branded Pharmaceutical Products R&D, et al.

Orange Book alert: Improper patent listings could be investigated as ...

Companies that manufacture and sell branded pharmaceuticals could soon face independent FTC actions for improper Orange Book listings. Therefore ...

#257 Throwing the Book at Orange Book Listings? The FTC's Views ...

Mika Ikeda, Senior Counsel, Competition Law, Johnson & Johnson. Related Links: Federal Trade Commission Statement Concerning Brand Drug ...

FTC to Sue Drug Managers Over Insulin Prices - WSJ

The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers over their tactics for negotiating prices for drugs including ...

An Antitrust Economist's Perspective on Recent FTC Scrutiny ...

Such a certification triggers an immediate right for the brand drug manufacturer to sue for infringement, and the FDA automatically grants a 30- ...

Rum and Coke: The FTC Targets Soft Drinks and Alcohol in the ...

"Today's enforcement policy statement should put the prescription drug manufacturers and pharmacy benefit managers on notice that these ...

The Federal Trade Commission launches probe into pharmacy ...

Noting that so many companies in the prescription drug supply chain are vertically integrated, the Federal Trade Commission voted unanimously on ...

Competition's role in controlling prescription drug prices

But the statute provides no enforcement mechanism. On multiple occasions, the FDA has tried to address the situation. In response to branded ...

What To Watch As The FTC Targets Drug Patent Listings

The commission raised concerns in a September policy statement about patents being improperly listed in the U.S. Food and Drug ...

Case: 4:24-cv-01263 Doc. #: 1 Filed: 09/17/24 Page: 1 of 58 PageID

... drug faces competition from alternative branded ... 110 See FTC, Majority Statement, Statement of the Federal Trade Commission Concerning the ...

FTC Sues Pharmacy Benefit Managers Over “Artificially Inflated ...

On September 20, 2024, the Federal Trade Commission (FTC) announced it had filed an administrative complaint against three pharmacy benefit managers ...

Orange You Glad You Didn't Try This: FTC and FDA Crack Down on ...

On September 14, 2023, the Federal Trade Commission (“FTC”) issued a Statement Concerning Brand Drug Manufacturers' Improper Listing of ...

AAI Report Examines FTC's Pharmaceutical Merger Policy in Light ...

AAI's macro-analysis of pharmaceutical mergers challenged by the FTC between 1994-2020 (to date) reveals that many drug makers engaged in serial mergers and/or ...

FTC: PBMs may 'urgently' require 'potential regulation'

“The FTC's interim report lays out how dominant pharmacy benefit managers can hike the cost of drugs—including overcharging patients for cancer ...

FACT SHEET: Biden-Harris Administration Announces New Actions ...

The Department of Justice (DOJ), the Federal Trade Commission (FTC) ... Building on Past Actions to Increase Health Care Competition and Lower ...